Watchers | 5,204 |
52-Wk Low | $1.89 |
52-Wk High | $6.37 |
Market Cap | $355.05M |
Volume | 34.93M |
52-Wk High | $6.37 |
52-Wk Low | $1.89 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Progenics Pharmaceuticals, Inc. market cap is $355.05M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Progenics Pharmaceuticals, Inc. 52 week high is $6.37 as of May 21, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Progenics Pharmaceuticals, Inc. 52 week low is $1.89 as of May 21, 2024.
Progenics Pharmaceuticals, Inc. stock price today is $4.10.
Progenics Pharmaceuticals, Inc. stock price yesterday was $4.53.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Progenics Pharmaceuticals, Inc.’s P/E ratio is None.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Progenics Pharmaceuticals, Inc. P/B ratio is 11.5976.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Progenics Pharmaceuticals, Inc.'s EBITDA is -5.74.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Progenics Pharmaceuticals, Inc. 50-day moving average is $4.06.
Progenics Pharmaceuticals, Inc. has 105 employees.